Vera Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts that cover Vera Therapeutics stock have a consensus rating of "Buy" and an average price target of $62.25, which forecasts a 110.66% increase in the stock price over the next year. The lowest target is $26 and the highest is $100.

Price Target: $62.25 (+110.66%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$26	$62.25	$61	$100
Change	-12.01%	+110.66%	+106.43%	+238.41%

Analyst Ratings

The average analyst rating for Vera Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	May '25	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25
Strong Buy	2	2	2	2	2	3
Buy	5	5	5	4	4	4
Hold	1	1	1	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	8	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Dina Ramadane B of A Securities	B of A Securities	Strong Buy Initiates $48	Strong Buy	Initiates	$48	+62.44%	Oct 16, 2025
Anupam Rama JP Morgan	JP Morgan	Buy Maintains $56 → $53	Buy	Maintains	$56 → $53	+79.36%	Aug 7, 2025
Andy Chen Wolfe Research	Wolfe Research	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Aug 4, 2025
Greg Harrison Scotiabank	Scotiabank	Buy Maintains $65 → $55	Buy	Maintains	$65 → $55	+86.13%	Jun 2, 2025
Arthur He HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $75 → $85	Strong Buy	Maintains	$75 → $85	+187.65%	Jun 2, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

37.36M

EPS This Year

-4.17

from -2.75

EPS Next Year

-4.74

from -4.17

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-	37.36M
Revenue Growth	-	-	-	-	-	-	-
EPS	-166.93	-2.43	-3.35	-2.25	-2.75	-4.17	-4.74
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	15	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	66.7M
Avg	n/a	37.4M
Low	n/a	2.5M

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-2.54	-3.26
Avg	-4.17	-4.74
Low	-4.77	-6.29

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.